Literature DB >> 22095716

Induction of endoplasmic reticulum-endosome fusion for antigen cross-presentation induced by poly (γ-glutamic acid) nanoparticles.

Yohei Mukai1, Tomoyo Yoshinaga, Mai Yoshikawa, Kazuhiko Matsuo, Tomoaki Yoshikawa, Keisuke Matsuo, Kazuyuki Niki, Yasuo Yoshioka, Naoki Okada, Shinsaku Nakagawa.   

Abstract

We previously reported that poly (γ-glutamic acid)-based nanoparticles (γ-PGA NPs) are excellent vaccine carriers for inducing efficient cross-presentation in dendritic cells, thereby producing strong antitumor immunity in vivo. Analyzing the mechanism of cross-presentation induced by γ-PGA NPs will be useful toward designing novel vaccine carriers. In this study, we show an intracellular mechanism of efficient cross-presentation induced by OVA-loaded γ-PGA NPs. Cross-presentation induced by γ-PGA NPs depended on cytoplasmic proteasomes and TAP, similar to the classical MHC class I presentation pathway for endogenous Ags. Intracellular behavior analyzed by confocal laser scanning microscopy revealed that encapsulated OVA and γ-PGA accumulated in both the endoplasmic reticulum (ER) and endosome compartments within 2 h. At the same time, electron microscopy analysis clearly showed that intracellular γ-PGA NPs and encapsulated Au NPs were enveloped in endosome-like vesicles, not in the ER. These findings strongly suggest that γ-PGA NPs enhance ER-endosome fusion for cross-presentation. Moreover, inhibition of ER translocon sec61 significantly decreased the γ-PGA NP/OVA-mediated cross-presentation efficiency, indicating that sec61 is important for transporting Ags from the fused ER-endosome to the cytoplasm. These findings imply that the ER-endosome complex is key for the efficient cross-presentation of Ags encapsulated in γ-PGA NPs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22095716     DOI: 10.4049/jimmunol.1001093

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Porous silicon microparticle potentiates anti-tumor immunity by enhancing cross-presentation and inducing type I interferon response.

Authors:  Xiaojun Xia; Junhua Mai; Rong Xu; Jorge Enrique Tovar Perez; Maria L Guevara; Qi Shen; Chaofeng Mu; Hui-Ying Tung; David B Corry; Scott E Evans; Xuewu Liu; Mauro Ferrari; Zhiqiang Zhang; Xian Chang Li; Rong-Fu Wang; Haifa Shen
Journal:  Cell Rep       Date:  2015-04-30       Impact factor: 9.423

Review 2.  Nanotechnology: Future of Oncotherapy.

Authors:  Kshipra M Gharpure; Sherry Y Wu; Chun Li; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Clin Cancer Res       Date:  2015-07-15       Impact factor: 12.531

3.  Delivery Order of Nanoconstructs Affects Intracellular Trafficking by Endosomes.

Authors:  Kwahun Lee; Insub Jung; Teri W Odom
Journal:  J Am Chem Soc       Date:  2022-03-18       Impact factor: 16.383

Review 4.  Emerging nanotechnologies for cancer immunotherapy.

Authors:  Sourabh Shukla; Nicole F Steinmetz
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-04

Review 5.  Nanopreparations for organelle-specific delivery in cancer.

Authors:  Swati Biswas; Vladimir P Torchilin
Journal:  Adv Drug Deliv Rev       Date:  2013-11-21       Impact factor: 15.470

Review 6.  The role of dendritic cells in graft-versus-tumor effect.

Authors:  Tomomi Toubai; Nathan Mathewson; Pavan Reddy
Journal:  Front Immunol       Date:  2014-02-21       Impact factor: 7.561

Review 7.  Nanocarrier-based immunotherapy in cancer management and research.

Authors:  Manu Smriti Singh; Sangeeta Bhaskar
Journal:  Immunotargets Ther       Date:  2014-06-26

8.  Poly-γ-glutamic acid/chitosan nanogel greatly enhances the efficacy and heterosubtypic cross-reactivity of H1N1 pandemic influenza vaccine.

Authors:  Jihyun Yang; Sang-Mu Shim; Thi Quyen Nguyen; Eun-Ha Kim; Kwang Kim; Yong Taik Lim; Moon-Hee Sung; Richard Webby; Haryoung Poo
Journal:  Sci Rep       Date:  2017-03-21       Impact factor: 4.379

Review 9.  Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunotherapy.

Authors:  Jianbo Jia; Yi Zhang; Yan Xin; Cuijuan Jiang; Bing Yan; Shumei Zhai
Journal:  Front Oncol       Date:  2018-09-25       Impact factor: 6.244

Review 10.  Synthetic Nanoparticles for Vaccines and Immunotherapy.

Authors:  Darrell J Irvine; Melissa C Hanson; Kavya Rakhra; Talar Tokatlian
Journal:  Chem Rev       Date:  2015-07-08       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.